Phase 1 and 3 trials demonstrated improved survival rates, with new treatment strategies for EGFR-mutated NSCLC, HER2+ breast cancer, and small-cell lung cancer. AI innovations, such as the ASCO ...
Impact of piflufolastat F18 imaging on disease management for prostate cancer patients: Observations from the PYLARIFY Registry study. This is an ASCO Meeting Abstract from the 2026 ASCO Genitourinary ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results